Skip to main content

Table 1 Baseline sociodemographic and clinical characteristics

From: Effectiveness of a village-based intervention for depression in community-dwelling older adults: a randomised feasibility study

 Total (n = 160)Intervention (n = 82)Control (n = 78)p*
Sociodemographic characteristics
 Age, years ± SD74.2 ± 5.774.9 ± 5.473.5 ± 5.90.120
 Female, n (%)94 (58.8)50 (61.0)44 (56.4)0.631
 Education, years ± SD5.1 ± 4.14.3 ± 3.95.9 ± 4.20.013
 Widowed/Divorced/Separated/Unmarried, n (%)38 (24.2)16 (20.3)22 (28.2)0.268
 Living alone, n (%)32 (20.4)13 (16.0)19 (25.0)0.173
 Medicaid, n (%)29 (18.1)20 (24.4)9 (11.5)0.041
Clinical characteristics
Lifetime
  History of depressive disorder, a n (%)38 (24.2)24 (30.4)14 (17.9)0.093
  History of suicidal ideation/plans/attempts, n (%)32 (21.8)21 (30.0)11 (14.3)0.028
Baseline
  Chronic medical illness, b n (%)112 (80.6)66 (83.5)46 (76.7)0.388
  Depressive disorder, a n (%)15 (9.6)10 (12.7)5 (6.4)0.277
  Suicidal ideation/plans/attempts, n (%)8 (5.5)7 (10.4)1 (1.3)0.025
  SGDS-K, c score ± SD3.0 ± 3.43.6 ± 3.72.4 ± 3.00.027
  LSNS-K, d score ± SD25.8 ± 9.223.1 ± 8.528.5 ± 9.1< 0.001
  S-IADL, e score ± SD2.2 ± 3.72.4 ± 3.72.0 ± 3.70.482
  MMSE-KC, f score ± SD25.6 ± 4.624.9 ± 5.326.2 ± 3.70.072
  1. * Student’s t-test for continuous variables and the chi-square test for categorical variables
  2. a Major or minor depressive episode as defined by the DSM-IV criteria
  3. b One or more chronic medical illnesses including hypertension, diabetes, dyslipidemia, cerebrovascular disease, and heart disease
  4. c Korean version of the Geriatric Depression Scale – Short Form; a higher score corresponds to more depressive symptoms (range: 0–15)
  5. d Korean version of the Lubben Social Network Scale; a higher score corresponds to a stronger social network (range: 0–50)
  6. e Seoul Instrumental Activities of Daily Living; a higher score corresponds to worse daily function (range: 0–45)
  7. f Mini-Mental State Examination; part of the neuropsychological battery of the Consortium to Establish a Registry for Alzheimer’s Disease; a higher score corresponds to better global cognitive function (range: 0–30)
\